Evidence map›Paper›PMID 32151228›Full record

SynthesisJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2020

UK consensus on pre-clinical vascular cognitive impairment functional outcomes assessment: Questionnaire and workshop proceedings.

Aisling McFall, Tuuli M Hietamies, Ashton Bernard, Margaux Aimable, Stuart M Allan, Philip M Bath, Gaia Brezzo, Roxana O Carare, Hilary V Carswell, Andrew N Clarkson and 28 more

Abstract readConsensus StatementSystematic Review
In one paragraph

Synthesis in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors.

Aisling McFallInstitute of Cardiovascular & Medical Sciences, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.
Tuuli M HietamiesInstitute of Cardiovascular & Medical Sciences, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.
Ashton BernardInstitute of Cardiovascular & Medical Sciences, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.
Margaux AimableCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Stuart M AllanLydia Becker Institute of Immunology and Inflammation, Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Philip M BathStroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK.
Gaia BrezzoCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Roxana O CarareFaculty of Medicine, University of Southampton, Southampton, UK.
Hilary V CarswellUniversity of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Science, Glasgow, UK.
Andrew N ClarksonThe Department of Anatomy, Brain Health Research Centre and Brain Research New Zealand, University of Otago, Dunedin, New Zealand.
Gillian CurrieCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Tracy D FarrSchool of Life Sciences, University of Nottingham, Nottingham , UK.ORCID 0000-0002-6781-5226
Jill H FowlerCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Mark GoodSchool of Psychology, Cardiff University, Cardiff, UK.
Atticus H HainsworthMolecular & Clinical Sciences Research Institute, St George's University of London, London, UK.ORCID 0000-0001-7877-8013
Catherine HallSchool of Psychology, University of Sussex, Brighton, UK.
Karen HorsburghCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Rajesh KalariaInstitute of Neuroscience, Newcastle University, Newcastle Upon Tyne, UK.
Patrick KehoeInstitute of Clinical Neurosciences, University of Bristol, Bristol, UK.
Catherine LawrenceLydia Becker Institute of Immunology and Inflammation, Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.ORCID 0000-0002-2372-2968
Malcolm MacleodCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Barry W McCollCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Alison McNeillySchool of Medicine, University of Dundee, Ninewells Hospital, Dundee, Scotland.
Alyson A MillerInstitute of Cardiovascular & Medical Sciences, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.ORCID 0000-0001-7755-9046
Scott MinersInstitute of Clinical Neurosciences, University of Bristol, Bristol, UK.
Vincent MokGerald Choa Neuroscience Centre, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.
Michael O'SullivanFaculty of Medicine, The University of Queensland, Queensland, Australia.
Bettina PlattInstitute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland.
Emily S SenaCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Matthew SharpFaculty of Medicine, University of Southampton, Southampton, UK.ORCID 0000-0002-6623-5078
Patrick StrangwardLydia Becker Institute of Immunology and Inflammation, Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Stefan SzymkowiakCentre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK.
Rhian M TouyzInstitute of Cardiovascular & Medical Sciences, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.
Rebecca C TruemanSchool of Life Sciences, University of Nottingham, Nottingham , UK.
Claire WhiteLydia Becker Institute of Immunology and Inflammation, Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Chris McCabeInstitute of Neuroscience & Psychology, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.ORCID 0000-0003-3111-031X
Lorraine M WorkInstitute of Cardiovascular & Medical Sciences, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.ORCID 0000-0002-6462-4109
Terence J QuinnInstitute of Cardiovascular & Medical Sciences, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.ORCID 0000-0003-1401-0181

Funding

British Heart Foundation FS/15/64/32035Medical Research Council MC_PC_13088Medical Research Council MR/L003384/1Medical Research Council MR/L023784/2Medical Research Council MR/S026495/1
6 · The paper itself

Abstract

Assessment of outcome in preclinical studies of vascular cognitive impairment (VCI) is heterogenous. Through an ARUK Scottish Network supported questionnaire and workshop (mostly UK-based researchers), we aimed to determine underlying variability and what could be implemented to overcome identified challenges. Twelve UK VCI research centres were identified and invited to complete a questionnaire and attend a one-day workshop. Questionnaire responses demonstrated agreement that outcome assessments in VCI preclinical research vary by group and even those common across groups, may be performed differently. From the workshop, six themes were discussed: issues with preclinical models, reasons for choosing functional assessments, issues in interpretation of functional assessments, describing and reporting functional outcome assessments, sharing resources and expertise, and standardization of outcomes. Eight consensus points emerged demonstrating broadly that the chosen assessment should reflect the deficit being measured, and therefore that one assessment does not suit all models; guidance/standardisation on recording VCI outcome reporting is needed and that uniformity would be aided by a platform to share expertise, material, protocols and procedures thus reducing heterogeneity and so increasing potential for collaboration, comparison and replication. As a result of the workshop, UK wide consensus statements were agreed and future priorities for preclinical research identified.

Indexed as

Dementia, VascularDisease Models, AnimalAnimalsConsensusRecovery of FunctionResearch DesignSurveys and QuestionnairesUnited KingdomDementiamethodologyoutcomesquestionnairevascular cognitive impairment

Identifiers

PMID32151228
PMCPMC7307003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.